Vir Biotechnology Inc (VIR)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	73,109	78,618	72,140	56,343	46,679	51,681	427,211	397,246	1,580,474	2,368,441	2,099,722	2,316,395	1,087,060	277,605	175,080	67,363	67,245	67,315	67,364	1,181
Total assets	US$ in thousands	1,398,810	1,498,360	1,669,560	1,793,970	1,960,090	2,044,900	2,243,870	2,665,940	2,802,090	2,695,970	2,618,990	2,887,130	1,954,270	1,210,210	1,057,580	1,135,580	918,761	943,259	672,238	477,114
Total asset turnover		0.05	0.05	0.04	0.03	0.02	0.03	0.19	0.15	0.56	0.88	0.80	0.80	0.56	0.23	0.17	0.06	0.07	0.07	0.10	0.00

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $73,109K ÷ $1,398,810K
= 0.05

The total asset turnover ratio of Vir Biotechnology Inc has shown fluctuations over the past years. From March 31, 2020, where the ratio was at its lowest at 0.00, there was a gradual increase in the ratio over the next quarters, reaching its peak at 0.88 on September 30, 2022. This indicates that the company was effectively generating revenue relative to its total assets during that period.

However, following the peak, the total asset turnover ratio started to decline, dropping to 0.02 by December 31, 2023. This downtrend continued into the following quarters until March 31, 2024, where the ratio slightly increased to 0.03.

Overall, the total asset turnover ratio of Vir Biotechnology Inc has been volatile, with periods of both strong and weak performance in terms of utilizing its assets to generate revenue. It would be essential for the company to closely monitor and manage this ratio to ensure efficient asset utilization and sustained revenue generation in the future.